Literature DB >> 17495866

Leprecan distribution in the developing and adult kidney.

M Lauer1, B Scruggs, S Chen, D Wassenhove-McCarthy, K J McCarthy.   

Abstract

The temporal and spatial deposition of extracellular matrix proteins is critical for nephrogenesis and glomerular maturation. We previously characterized leprecan as a novel chondroitin sulfate proteoglycan which has been recently shown to have prolyl hydroxylase activity. In this study, we examine the distribution of leprecan during nephrogenesis and after a hypertrophic stimulus to the adult kidney. During development, leprecan was localized to mesenchymal aggregates, early comma- and S-phase structures as determined by immunohistochemistry and in situ hybridization. Leprecan mRNA was increased in cells around the vascular cleft of the S- and comma-phase glomeruli. Expression was found in podocytes, mesangial cells, and parietal epithelial cells of loop-phase glomeruli. Leprecan mRNA was substantially decreased in the glomeruli of the adult kidney compared to the developing kidney with a uniform distribution between the glomeruli and the tubules. Within adult glomeruli, leprecan was found in the mesangium mesangial matrix, podocytes, and in Bowman's capsule. In response to glomerular hypertrophy, produced by unilateral nephrectomy, leprecan synthesis was increased in the adult kidney. We suggest that the regulated expression of leprecan during glomerular development or hypertrophy coupled with its reported prolyl hydroxylase activity plays a role during basement membrane assembly.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17495866     DOI: 10.1038/sj.ki.5002269

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  Podocytes require the engagement of cell surface heparan sulfate proteoglycans for adhesion to extracellular matrices.

Authors:  Shoujun Chen; Deborah Wassenhove-McCarthy; Yu Yamaguchi; Lawrence Holzman; Toin H van Kuppevelt; A Wayne Orr; Steven Funk; Ann Woods; Kevin McCarthy
Journal:  Kidney Int       Date:  2010-05-12       Impact factor: 10.612

2.  Non-Lethal Type VIII Osteogenesis Imperfecta Has Elevated Bone Matrix Mineralization.

Authors:  Nadja Fratzl-Zelman; Aileen M Barnes; MaryAnn Weis; Erin Carter; Theresa E Hefferan; Giorgio Perino; Weizhong Chang; Peter A Smith; Paul Roschger; Klaus Klaushofer; Francis H Glorieux; David R Eyre; Cathleen Raggio; Frank Rauch; Joan C Marini
Journal:  J Clin Endocrinol Metab       Date:  2016-07-06       Impact factor: 5.958

Review 3.  Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta.

Authors:  Joan C Marini; Wayne A Cabral; Aileen M Barnes
Journal:  Cell Tissue Res       Date:  2009-10-28       Impact factor: 5.249

4.  Conservation of notochord gene expression across chordates: insights from the Leprecan gene family.

Authors:  Terence D Capellini; Matthew P Dunn; Yale J Passamaneck; Licia Selleri; Anna Di Gregorio
Journal:  Genesis       Date:  2008-11       Impact factor: 2.487

Review 5.  Biological functions of iduronic acid in chondroitin/dermatan sulfate.

Authors:  Martin A Thelin; Barbara Bartolini; Jakob Axelsson; Renata Gustafsson; Emil Tykesson; Edgar Pera; Åke Oldberg; Marco Maccarana; Anders Malmstrom
Journal:  FEBS J       Date:  2013-03-28       Impact factor: 5.542

6.  Sc65-Null Mice Provide Evidence for a Novel Endoplasmic Reticulum Complex Regulating Collagen Lysyl Hydroxylation.

Authors:  Melissa E Heard; Roberta Besio; MaryAnn Weis; Jyoti Rai; David M Hudson; Milena Dimori; Sarah M Zimmerman; Jeffrey A Kamykowski; William R Hogue; Frances L Swain; Marie S Burdine; Samuel G Mackintosh; Alan J Tackett; Larry J Suva; David R Eyre; Roy Morello
Journal:  PLoS Genet       Date:  2016-04-27       Impact factor: 5.917

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.